Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, May 9, 2024
[ Thu, May 09th 2024
] - WOPRAI
[ Thu, May 09th 2024
] - WOPRAI
[ Thu, May 09th 2024
] - WOPRAI
[ Thu, May 09th 2024
] - WOPRAI
[ Thu, May 09th 2024
] - WOPRAI
[ Thu, May 09th 2024
] - WOPRAI
[ Thu, May 09th 2024
] - WOPRAI
[ Thu, May 09th 2024
] - WOPRAI
[ Thu, May 09th 2024
] - WOPRAI
[ Thu, May 09th 2024
] - WOPRAI
[ Thu, May 09th 2024
] - WOPRAI
[ Thu, May 09th 2024
] - WOPRAI
[ Thu, May 09th 2024
] - WOPRAI
[ Thu, May 09th 2024
] - WOPRAI
[ Thu, May 09th 2024
] - WOPRAI
[ Thu, May 09th 2024
] - WOPRAI
[ Thu, May 09th 2024
] - WOPRAI
[ Thu, May 09th 2024
] - WOPRAI
[ Thu, May 09th 2024
] - WOPRAI
[ Thu, May 09th 2024
] - WOPRAI
[ Thu, May 09th 2024
] - WOPRAI
[ Thu, May 09th 2024
] - WOPRAI
[ Thu, May 09th 2024
] - WOPRAI
[ Thu, May 09th 2024
] - WOPRAI
[ Thu, May 09th 2024
] - WOPRAI
[ Thu, May 09th 2024
] - WOPRAI
[ Thu, May 09th 2024
] - WOPRAI
Douglas Tsao Maintained (VRDN) at Strong Buy with Decreased Target to $27 on, May 9th, 2024
Douglas Tsao of HC Wainwright & Co., Maintained "Viridian Therapeutics, Inc." (VRDN) at Strong Buy with Decreased Target from $37 to $27 on, May 9th, 2024.
Douglas has made no other calls on VRDN in the last 4 months.
There is 1 other peer that has a rating on VRDN. Out of the 1 peers that are also analyzing VRDN, 0 agree with Douglas's Rating of Hold.
This is the rating of the analyst that currently disagrees with Douglas
- Laura Chico of "Wedbush" Maintained at Buy with Increased Target to $40 on, Wednesday, February 28th, 2024
